Neuphoria Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $28.6M
Liabilities Breakdown FY2023
Total Liabilities: $6.6M
Asset Breakdown
Total Assets: $28.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $12.1M | 42.4% |
| Accounts Receivable | $426.1K | 1.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.5K | 0.0% |
| Goodwill | $8.7M | 30.4% |
| Intangible Assets | $6.1M | 21.5% |
| Other Assets | $1.2M | 4.2% |
Liabilities Breakdown
Total Liabilities: $6.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 22.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.1M | 78.0% |